Get the Stockscreener App
6.05
2.58%
-0.16
Coya Therapeutics Inc stock is traded at $6.05, with a volume of 190.06K.
It is down -2.58% in the last 24 hours and down -1.31% over the past month.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
See More
Previous Close:
$6.21
Open:
$6.25
24h Volume:
190.06K
Relative Volume:
2.44
Market Cap:
$101.19M
Revenue:
-
Net Income/Loss:
$-14.88M
P/E Ratio:
-6.1735
EPS:
-0.98
Net Cash Flow:
$-10.29M
1W Performance:
-3.51%
1M Performance:
-1.31%
6M Performance:
-8.75%
1Y Performance:
+1.51%
1-Day Range:
$5.78
$6.423
1-Week Range:
$5.78
$6.525
52-Week Range:
$4.65
$10.24
Coya Therapeutics Inc Stock (COYA) Company Profile
Name
Coya Therapeutics Inc
Sector
Industry
Phone
650.739.3939
Address
12645 MEMORIAL DR., SUITE F1 #305, HOUSTON
Compare COYA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
COYA
Coya Therapeutics Inc
|
6.05 | 105.54M | 0 | -14.88M | -10.29M | -0.98 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Coya Therapeutics Inc Stock (COYA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-09-25 | Initiated | Lake Street | Buy |
| Dec-04-24 | Initiated | D. Boral Capital | Buy |
Coya Therapeutics Inc Stock (COYA) Latest News
heatmap analysis for coya therapeutics inc. and competitorsOptions Play & Free Expert Verified Stock Movement Alerts - Newser
Statistical indicators supporting Coya Therapeutics Inc.’s strength2025 Technical Patterns & Consistent Income Trade Recommendations - Newser
Heatmap analysis for Coya Therapeutics Inc. and competitorsTreasury Yields & Free Real-Time Volume Trigger Notifications - Newser
Coya Therapeutics Inc. stock momentum explained2025 Price Action Summary & Weekly Chart Analysis and Trade Guides - Newser
What institutional flow reveals about Coya Therapeutics Inc.July 2025 Catalysts & Reliable Price Action Trade Plans - Newser
Will earnings trigger a reversal in Coya Therapeutics Inc.Index Update & Consistent Growth Equity Picks - Newser
Exit strategy if you’re trapped in Coya Therapeutics Inc.Quarterly Earnings Summary & Weekly Watchlist for Hot Stocks - Newser
Using portfolio simulators with Coya Therapeutics Inc. includedTrend Reversal & Verified Technical Signals - Newser
Applying big data sentiment scoring on Coya Therapeutics Inc.Take Profit & Risk Controlled Stock Pick Alerts - Newser
Published on: 2025-09-11 16:36:25 - Newser
How high can Coya Therapeutics Inc. stock goWeekly Trade Recap & Verified Momentum Watchlists - Newser
Will Coya Therapeutics Inc. stock recover after recent dropMarket Activity Summary & AI Optimized Trading Strategy Guides - Newser
Has Coya Therapeutics Inc. found a price floorInsider Buying & Verified Entry Point Detection - Newser
Coya Therapeutics' (COYA) Buy Rating Reiterated at D. Boral Capital - MarketBeat
Using economic indicators to assess Coya Therapeutics Inc. potentialWeekly Market Report & AI Powered Buy and Sell Recommendations - Newser
Real time alert setup for Coya Therapeutics Inc. performanceJuly 2025 Macro Moves & Safe Entry Momentum Tips - Newser
Coya Therapeutics Highlights Q2 2025 Financial Results - MSN
Multi factor analysis applied to Coya Therapeutics Inc.Risk Management & Real-Time Volume Analysis Alerts - Newser
Is a relief rally coming for Coya Therapeutics Inc. holders2025 Technical Overview & Weekly High Return Stock Forecasts - Newser
What’s the recovery path for long term holders of Coya Therapeutics Inc.July 2025 Levels & Precise Buy Zone Identification - Newser
Price Action Confirms Reversal in Coya Therapeutics Inc. TrendJuly 2025 Trends & Weekly Watchlist of Top Performers - beatles.ru
A | Sector Rotation Brings Coya Therapeutics, Inc. Into FocusJuly 2025 Review & Long-Term Growth Stock Strategies - beatles.ru
Aug Retail: Can Coya Therapeutics Inc. expand into new marketsJuly 2025 Volume & Technical Pattern Alert System - خودرو بانک
D. Boral Capital Reiterates Buy Rating for Coya Therapeutics (NASDAQ:COYA) - Defense World
How to forecast Coya Therapeutics Inc. trends using time seriesMarket Movers & Low Drawdown Momentum Trade Ideas - Newser
does coya therapeutics inc. show high probability of reboundMarket Trend Report & Weekly Market Pulse Alerts - Newser
Quarterly Recap: Is now the right time to enter Coya Therapeutics Inc.Weekly Loss Report & AI Forecast Swing Trade Picks - خودرو بانک
Does Coya Therapeutics Inc. show high probability of reboundQuarterly Portfolio Report & AI Forecast for Swing Trade Picks - Newser
Coya Therapeutics' COYA 302 ALS Trial Accepted by NEALS as a NEALS-Affiliated Trial - StreetInsider
Earnings visualization tools for Coya Therapeutics Inc.Breakout Watch & Technical Entry and Exit Tips - Newser
Can Coya Therapeutics Inc. expand into new marketsQuarterly Portfolio Report & Low Drawdown Momentum Trade Ideas - خودرو بانک
Visual trend scoring systems applied to Coya Therapeutics Inc.Short Setup & Daily Volume Surge Trade Alerts - Newser
Applying Elliott Wave Theory to Coya Therapeutics Inc.2025 Valuation Update & Fast Moving Stock Trade Plans - Newser
Does Coya Therapeutics Inc. stock have upside surprise potential2025 Technical Patterns & Weekly Breakout Stock Alerts - خودرو بانک
Will Coya Therapeutics Inc. benefit from seasonalityJuly 2025 Earnings & Safe Investment Capital Preservation Plans - خودرو بانک
Coya Therapeutics to Participate at Upcoming September Investor Conferences - Eastern Progress
Coya Therapeutics shares rise 1.20% premarket after FDA acceptance of COYA 302 IND for ALS trial. - AInvest
Coya Therapeutics' ALS Trial Affiliated with NEALS, Preparing for Q4 2025 Initiation - AInvest
Coya Therapeutics Inc Stock (COYA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Coya Therapeutics Inc Stock (COYA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| SNYDER DAVID S | Chief Financial Officer |
Nov 14 '24 |
Buy |
7.19 |
1,800 |
12,934 |
8,800 |
| Swaminathan Arun | Chief Executive Officer |
Nov 13 '24 |
Buy |
7.36 |
5,000 |
36,797 |
10,000 |
| Grossman Fred | Chief Medical Officer |
Nov 11 '24 |
Buy |
7.37 |
2,710 |
19,973 |
2,710 |
| Swaminathan Arun | Chief Executive Officer |
Nov 11 '24 |
Buy |
7.34 |
5,000 |
36,689 |
5,000 |
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):